Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-05-26

FDA Approved: IRINOTECAN HYDROCHLORIDE — Original Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved IRINOTECAN HYDROCHLORIDE as a generic drug under an Original Application by Ingenus Pharmaceuticals, LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IRINOTECAN HYDROCHLORIDE (irinotecan hydrochloride)

Snippet

ORIG AP for IRINOTECAN HYDROCHLORIDE (IRINOTECAN HYDROCHLORIDE)